Tomasz Brzoska on How Personalized Medicine Benefits SCD Patients
Tomasz Brzoska, Assistant Professor of Medicine in University of Pittsburgh, School of Medicine, shared on LinkedIn:
”Our newest study has just been published.
See how personalized medicine can potentially benefit sickle cell disease patients!
Big thanks to all collaborators and contributors, especially Prithu Sundd, PhD , PhD and Tomasz Kaminski.
Most of the studies were performed at University of Pittsburgh School of Medicine and Vascular Medicine Institute.”
Read the full article here.
Article: CD39 polymorphism enables lung thrombosis in sickle cell disease
Authors: Tomasz Brzoska, Tomasz W. Kaminski, Omika Katoch, Elizaveta V. Menchikova, Adekunle E. Alagbe, Sarah E. Tashbook, Stevan P. Tofovic, Jude C. Jonassaint, Claudette M. St. Croix, Simon C. Watkins, Shane Howe, Joshua J. Field, Amanda A. Seyerle, Tirthadipa Pradhan-Sundd, Cecilia Laurie, Nathan D. Pankratz, Nicholas L. Smith, Ellen L. Goode, James S. Pankow, Charles Kooperberg, Gregory J. Kato, Yingze Zhang, Enrico M. Novelli, Mark T. Gladwin, Edwin K. Jackson, Seyed M. Nouraie, Prithu Sundd
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters